Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
alferminogene tadenovec (4 trials)
Key: Gene Biotherapeutics, Inc. (0) Acquired (1)
gam501 (2 trials)
Angina Pectoris (Phase 3)
Angina, Stable (Phase 3)
Coronary Artery Disease (Phase 3)
Diabetic Foot (Phase 2)
Myocardial Ischemia (Phase 3)
Trials (6 total)
Trial APIs (2 total)